Penn State Science says the new funding supports work that uses AI to identify synthetic peptides with potential for drug development.
Recap by typeshit. Post by @PSUScience on X.
An explainer on how GLP-1 drugs act on reward and craving in the brain, and the research testing them against alcohol, nicotine and other substance use.
Dr Alo, a cardiologist, says he is following the cardiovascular data on these drugs closely and that it is shifting how heart disease is treated.
50:28
DOWNSIZED looks at why appetite and food noise can creep back late in the weekly cycle, and what that may say about whether a GLP-1 is still working.
Avi Roy points to trial data on drugs like Ozempic, including a 16-week study of 73 people where milkshake ratings barely changed despite reduced appetite.
MedShadow rounds up FDA recalls at three compounders, including Carolina Infusion and Apothecary Pharma, plus inspection findings on sterile processing.
Reuters reports the FDA filed the change on Thursday, a formal step that could make it easier for pharmacies to compound some peptides now off limits.
Loading…